Advertisement

Topics

Viral Pleuritis - Biotech, Pharma and Life Science Channel

01:27 EDT 1st June 2016 | BioPortfolio

Viral pleuritis is a viral infection of the pleurae.

Viral pleuritis is most commonly caused by infection with coxsackie B virus. Occasionally, echovirus causes a rare condition known as epidemic or Bornholm's pleurodynia, manifesting as pleuritis, fever, and chest muscle spasms. The condition occurs in the late summer and affects adolescents and young adults. The primary symptom of viral pleuritis is pleuritic pain; pleural friction rub may be a sign.  Diagnosis is suspected in patients with pleuritic chest pain with or without systemic symptoms of viral infection. Chest x-ray is usually done. Other causes of pleuritic chest pain, such as pulmonary emboli and pneumonia, need to be considered and sometimes ruled out with testing. Treatment is symptomatic, with oral NSAIDs or a short course of oral opioids if needed.

Soruce; Merck Manuals

Add the Pleuritis News Channel to your RSS reader;

PubMed Articles [2366 Associated PubMed Articles listed on BioPortfolio]

Blood-borne viral co-infections among human immunodeficiency virus-infected inmates.

Purpose - The purpose of this paper is to evaluate the prevalence of HBV and/or HCV co-infection among HIV-infected inmates entering the correctional facility. Design/methodology/approach - Prospectiv...

An Overlap Syndrome involving systemic lupus erythematosus and autoimmune hepatitis in an adolescent girl.

Overlap of systemic lupus erythematosus and autoimmune hepatitis is a rare condition, occasionally described. Both autoimmune diseases can share common autoimmune features such as polyartralgia, hyper...

Recurrent rhabdomyolysis in a child. Case presentation.

Viral myositis associated with infections rarely may cause rhabdomyolysis. There is no any pediatric case with severe recurrent rhabdomyolysis triggered by infections in the literature. We reported a ...

Norovirus in Transplantation.

Noroviruses are among the most common cause of diarrhea in transplant recipients. The clinical spectrum of norovirus infection after transplant is increasingly being recognized. As substantial morbidi...

Small Intestinal Infections.

Small intestinal infections are extremely common worldwide. They may be bacterial, viral, or parasitic in etiology. Most are foodborne or waterborne, with specific etiologies differing by region and w...

Eradication Strategies for Chronic Hepatitis B Infection.

Chronic hepatitis B infection affects >300 million people worldwide and is a leading cause of liver failure and cancer. Current approaches to treatment for chronic hepatitis B involve suppression of h...

Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.

Liver disease associated with persistent infection with hepatitis B virus (HBV) continues to be a major health problem of global impact. Despite the existence of an effective vaccine, at least 240 mil...

Circumscribed Hypokeratosis: Report on a Series of 7 Mexican Cases and Review of the Literature.

Circumscribed palmoplantar hypokeratosis is a recently described condition with well-defined clinical and histopathologic features. Eight additional cases from Mexican patients-six cases have been pub...

Disseminated Varicella-Zoster Virus After Vaccination in an Immunocompetent Patient.

Severe adverse events associated with varicella-zoster virus (VZV) vaccination are rare. The authors describe a 53-year-old woman with no known immunodeficiency who presented with diffuse pruritic ras...

Use of three-dimensional accelerometers to evaluate behavioral changes in cattle experimentally infected with bovine viral diarrhea virus.

OBJECTIVE To assess the use of 3-D accelerometers to evaluate behavioral changes in cattle experimentally infected with a low-virulent strain of bovine viral diarrhea virus (BVDV). ANIMALS 20 beef ste...

News Articles [792 Associated News Articles listed on BioPortfolio]

Maxim likes ContraVir merger with Ciclofilin

The merger of ContraVir Pharmaceuticals (NASDAQ:CTRV) with closely-held Ciclofilin Pharmaceuticals strengthens ContraVir’s position in the hepatitis B virus (HBV) space, according to a new report fr...

Hepatitis B Foundation Advocates are ‘Making the Link’ Between Viral Hepatitis and Liver Cancer in Philadelphia

Hepatitis and cancer advocates urge Philadelphia city leaders to help decrease liver cancer rates by making chronic viral hepatitis testing and treatment a local priority PHILADELPHIA, PA (PRWEB) May ...

FDA Grants Accelerated Approval to Intercept's Ocaliva

Intercept Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today announced that the U...

Transfection Methods in Gene Therapy

Immunotherapies against cancer, vaccines against new viruses (or old viruses in new places), and attempts to resolve pathogenic single-cell defects—all are looking to incorporate transfec...

Hepatitis B Foundation Advocates are ‘Making the Link’ Between Viral Hepatitis and Liver Cancer in Philadelphia

PHILADELPHIA, PA (PRWEB) May 31, 2016 More than 80 representatives of the Hepatitis B Foundation , Hepatitis C Allies of Philadelph...

Study identifies a new regulator of immune responses.

T cells are the immune cells responsible for recognizing and destroying specific invaders, such as viruses, bacteria, or cancer. Their activity is highly tunable, with signals from other cells adjusti...

ViiV Healthcare and the International Association of Providers of AIDS Care (IAPAC) to Collaborate on Fast-Track Cities

LONDON and WASHINGTON, May 31, 2016 /PRNewswire/ -- Collaboration will focus on 16 cities where HIV is highly prevalent and will help monitor progress towards the attainment of UNAIDS 90-90-90 and ze...

NanoViricides Signs Agreement with St. Jude Children's Research Hospital for further Influenza Drug Development

SHELTON, Conn., May 31, 2016 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC (the "Company") announced today that it has entered into an agreement with St. Jude Children's Research Hospital, Memph...

Governments on Track to Eliminate Viral Hepatitis by 2030

LONDON, May 30, 2016 /PRNewswire/ -- On 28 May, 194 Member States made a historic commitment to eliminate viral hepatitis by 2030. At the 69th World Health Assembly, governments unanimously voted to ...

Identifying how merkel cell polyomavirus infection can cause a lethal carcinoma

A benign virus normally found in the skin can lead to a type of rare, lethal skin cancer. Specifically, infection by the Merkel cell polyomavirus can lead to Merkel cell carcinoma in immune-compromise...

Events [0 Results]

None

Companies [67 Associated Companies listed on BioPortfolio]

Redox Pharmaceutical Corporation

Redox is a bio-pharmaceutical company that has developed chemical compounds shown in preclinical studies to be effective in the treatment and prevention of various viral and inflammatory diseases. Suc...

GenScript Corp

GenScript is a leader in providing services and products that are used in biological research to the scientific community around the world. We specialize in custom gene and peptide synthesis, siRNA co...

REPLICor Inc

REPLICor Inc. is a biopharmaceutical company developing novel broad-spectrum antiviral drugs. Its lead compound, REP 9, is active against 12 viral families including influenza, hepatitis B and C, HIV,...

Transgene S.A.

Transgene (Euronext: TNG), part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering and developing targeted immunotherapies for th...

Aalto Bio Reagents Ltd

Aalto Bio Reagents supplies a broad range of purified human proteins; polyclonal antisera; purified monoclonal and polyclonal antibodies; fungal, protozoan, bacterial and viral antigens; and disease s...

MeMed Ltd.

MeMed is dedicated to improving patient lives through research, development and commercialization of pioneering products that decode the immune system's distinct responses to diff...

Conkwest, Inc.

Conkwest is an innovative immuno-oncology company that is developing and commercializing a portfolio of highly potent and selective cellular therapies for the treatment of cancers...

SIRION Biotech GmbH

Founded in 2005, SIRION Biotech is a global leader in developing research and commercial grade viral vector solutions for industry and academic partners who are developing gene th...

4D Molecular Therapeutics

4DMT is a global leader in gene therapy product research & development. 4DMT and our partners are using scientific innovation to unlock the full potential of gene therapy for pati...

Global Virus Network

The Global Virus Network (GVN) is an independent organization comprised of leading medical virologists from Argentina, Australia, Canada, China, Germany, India, Ireland, Israel, I...

Clinical Trials [807 Associated Clinical Trials listed on BioPortfolio]

Dynamic Liver Tests in Liver Disease

Chronic viral hepatitis often leads to liver scarring - cirrhosis. If the virus is eradicated from the liver, the liver scarring and liver function often recovers. In some patients the dam...

Epic Allies HIV ART Adherence Intervention

This is a two-arm, randomized-controlled trial (RCT) that will test the acceptability, impact, and long-term sustainability of the Epic Allies intervention application (app), a theory-base...

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

To assess the safety and biological efficacy of therapeutically administered most closely HLA-matched third party donor-derived specific cytotoxic T lymphocytes (CTLs) targeting cytomegalo...

Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B Carriers

There has been no report on whether the patients with colorectal cancer who are also inactive Hepatitis B Carriers should receive Prophylactic Use or preemptive Use of an Anti-viral Drug E...

Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers

There has been no report on whether the patients with gastric cancer who are also inactive Hepatitis B carriers should receive prophylactic use or preemptive Use of an Anti-viral Drug Ente...

Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings

Several reports indicate that treatment failure due to HIV resistance or to adverse event-related discontinuation could compromise the effectiveness of scaling-up antiretroviral treatment ...

Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4

This is a prospective, cohort study in Faculty of Medicine, Zagazig University, Egypt. From June to December, 2016, investigators will follow up patients with chronic Hepatitis C virus gen...

A Peer-based Mobile-health Intervention to Increase Access and Adherence to Hepatitis C Treatment and HIV Viral Suppression

The purpose of this study is to test an intervention designed to train persons who inject drugs (PWID) and are infected with hepatitis C (HCV) and HIV in communication skills to 1) promote...

Striving Towards EmPowerment and Medication Adherence (STEP-AD)

Striving Towards Empowerment and Medication Adherence (STEP-AD) is a research study aimed at developing an intervention for Black women living with HIV to address psychosocial factors (i.e...

Pharmacotherapy Follow-up in Older HIV-infected Patients

Cardiovascular diseases (CVD) are the main cause of death in Spain. In HIV patients, the uncontrolled viral replication, antiretroviral therapy (ART) and coinfections contribute to develop...

Videos

None available.

Medical and Biotech [MESH] Definitions

Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell.

Immunoglobulins produced as a response to VIRAL ANTIGENS; includes all classes of immunoglobulins elicited by all viral components.

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

A species of gram-negative, facultatively anaerobic coccobacillus-shaped bacteria that has been isolated from pneumonic lesions and blood. It produces pneumonia with accompanying fibrinous pleuritis in swine.

The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid (VIRAL DNA or VIRAL RNA) to form a VIRUS PARTICLE.

Quick Search
Advertisement
 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

review and buy Viral Pleuritis market research data and corporate reports here

Channels Quicklinks